Products Antibodies Polyclonal Antibodies Anti-ENTPD1/CD39 Polyclonal Antibody for WB, IF, IHC-P - P49961

No Image

Polyclonal Antibodies

Anti-ENTPD1/CD39 Polyclonal Antibody for WB, IF, IHC-P - P49961

Item Number : CM0026064

Price varies based on specs and customizations


Application
WB, IF/ICC, IF-P, IHC-P, ELISA
Cross Reactivity
Human, Mouse, Rat
Protein Weight
58kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name ENTPD1/CD39 Rabbit pAb
Remarks/Alias CD39; SPG64; ATPDase; NTPDase-1; ENTPD1/CD39
Species Human
GeneID (Human) 953
GeneID 953
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 1-180 of human ENTPD1/CD39 (NP_001157655.1)
Source Rabbit
Category Polyclonal Antibodies
Application WB, IF/ICC, IF-P, IHC-P, ELISA
Cross Reactivity Human, Mouse, Rat
SWISS P49961
Protein Weight 58kDa
Shipping Ice bag

Biological Background: ENTPD1/CD39 Function and Localization

  • ENTPD1, also known as CD39, is an ectonucleoside triphosphate diphosphohydrolase 1 (NTPDase1) belonging to the ENTPD family.
  • It catalyzes the hydrolysis of nucleoside triphosphates (NTPs) and diphosphates (NDPs) in a sequential two-step reaction, converting NTPs to nucleoside monophosphates (NMPs) via NDP intermediates. Related references: PMID:8529670, PMID:8626624, PMID:8955160
  • This activity regulates extracellular nucleotide levels; by hydrolyzing proinflammatory ATP and platelet-activating ADP, it blocks platelet aggregation and supports blood flow. Related references: PMID:8955160, PMID:8996251
  • The protein localizes to the plasma membrane and caveolae, consistent with its function as an ecto-enzyme.
  • Tissue expression includes activated lymphoid cells, endothelial tissues, and high levels in placenta, lung, skeletal muscle, and kidney. Related references: PMID:7930580, PMID:8955160
  • Post-translational modifications include glycosylation, disulfide bonds, and palmitoylation, which are important for membrane anchoring and enzymatic function.
  • Mutations in ENTPD1 are associated with hereditary spastic paraplegia (SPG64).
  • Alternative splicing produces multiple isoforms of the protein.

Experimental Guidance and Technical Tips

  • The immunogen corresponds to the N-terminal region (aa 1-180) which includes part of the extracellular domain; this design may favor detection of surface-localized or full-length ENTPD1/CD39.
  • For western blotting, the predicted molecular weight of ~58 kDa (unmodified) should be validated in the relevant sample system, as glycosylation may cause a higher apparent molecular weight.
  • When using immunohistochemistry (IHC-P) or immunofluorescence (IF/ICC, IF-P), consider antigen retrieval methods and validate with appropriate controls, given the membrane-bound localization of the target.
  • The reported cross-reactivity with mouse and rat makes this antibody potentially suitable for comparative studies; however, verify species-specific reactivity in your experimental setup.
  • For ELISA applications, optimize coating antigen and detection conditions for best performance.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio serves as a comprehensive one-stop partner for IVD raw-material sourcing, offering validated antibody pairs, optimized polyclonal antibodies, bulk ancillary reagents, and rare target sourcing. This anti-ENTPD1/CD39 product supports research into purinergic signaling, immunology, and vascular biology. Leverage our supply capabilities to streamline your diagnostic development from concept to clinic.

View more faqs for this product

Product Datasheet

Anti-ENTPD1/CD39 Polyclonal Antibody for WB, IF, IHC-P - P49961


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!